From Yahoo Finance: 2025-05-07 22:19:00

Gilead Sciences (NASDAQ: GILD) is a biopharmaceutical company developing medicines in the U.S. and internationally, with a 52-week stock price range of $62.07 to $119.96. The company’s dividend yield is 3.05%, paying $3.16 per share in dividends over the last 12 months.

In Q1 2025, Gilead Sciences reported EPS of $1.81, beating estimates, with revenue of $6.67 billion, missing analyst consensus. The company lowered its full-year EPS guidance to $5.65-$6.05 from $5.95-$6.35, compared to the consensus of $6.21.

To earn $100 per month from Gilead Sciences dividends, an investment value of approximately $39,344 is needed, equivalent to around 379 shares at $103.68 each. Investors may find the stock attractive for generating steady income with consistent dividend hikes over the past 10 years.

Read more: How To Put $100 In Your Retirement Fund Each Month With Gilead Sciences Stock